Reply
Christian von Loeffelholz, Andreas L. Birkenfeld – 12 October 2017
Longterm outcome of rendezvous technique for hepaticojejunal anastomotic obstruction after pediatric living donor liver transplantation
Yukihiro Sanada, Tomonori Yano, Taizen Urahashi, Yoshiyuki Ihara, Noriki Okada, Naoya Yamada, Yuta Hirata, Takumi Katano, Hironori Yamamoto, Koichi Mizuta – 12 October 2017
Current status of liver transplantation for cholangiocarcinoma
Nicolás Goldaracena, Andre Gorgen, Gonzalo Sapisochin – 11 October 2017 – Cholangiocarcinoma (CCA) is the second most common liver cancer, and it is associated with a poor prognosis. CCA can be divided into intrahepatic, hilar, and distal. Despite the subtype, the median survival is 12‐24 months without treatment. Liver transplantation (LT) is recognized worldwide as a curative option for hepatocellular carcinoma. On the other hand, the initial results for LT for CCA were very poor mainly due to a lack of adequate patient selection.
Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation
Sangbin Han, Sanghoon Lee, Ju Dong Yang, Michael Douglas Leise, Joong Hyun Ahn, Seonwoo Kim, Kangha Jung, Mi Sook Gwak, Gaab Soo Kim, Justin Sangwook Ko – 11 October 2017 – Platelets interact with tumor cells and promote metastasis. The importance of platelets in posttransplant hepatocellular carcinoma (HCC) recurrence is unclear. Thus, we aimed to evaluate the association between preoperative platelet count (PLT) and HCC recurrence after living donor liver transplantation.
Current status of liver transplantation for cholangiocarcinoma
Nicolás Goldaracena, Andre Gorgen, Gonzalo Sapisochin – 11 October 2017 – Cholangiocarcinoma (CCA) is the second most common liver cancer, and it is associated with a poor prognosis. CCA can be divided into intrahepatic, hilar, and distal. Despite the subtype, the median survival is 12‐24 months without treatment. Liver transplantation (LT) is recognized worldwide as a curative option for hepatocellular carcinoma. On the other hand, the initial results for LT for CCA were very poor mainly due to a lack of adequate patient selection.
Con: Treating hepatitis C virus With direct‐acting antivirals: Fear not the perceived threat of hepatocellular carcinoma
Neil Mehta, Francis Y. Yao – 11 October 2017
Pro: Direct‐acting antivirals are associated with occurrence and recurrence of hepatocellular carcinoma
James F. Trotter – 11 October 2017
Reply
Sarah Shalaby, Alberto Zanetto, Alessandro Vitale, Martina Gambato, Umberto Cillo, Fabio Farinati, Patrizia Burra, Francesco Paolo Russo – 11 October 2017
Exercise and physical activity for patients with end‐stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list
Andrés Duarte‐Rojo, Astrid Ruiz‐Margáin, Aldo J. Montaño‐Loza, Ricardo U. Macías‐Rodríguez, Arny Ferrando, W. Ray Kim – 11 October 2017 – Sarcopenia and physical deconditioning are frequent complications in patients with cirrhosis and end‐stage liver disease (ESLD). They are the end result of impaired dietary intake, chronic inflammation, altered macronutrient and micronutrient metabolism, and low physical activity. Frailty is the end result of prolonged sarcopenia and physical deconditioning.
Pembrolizumab for metastatic hepatocellular carcinoma following live donor liver transplantation: The silver bullet?
Ashwin Rammohan, Mettu S. Reddy, Mohammed Farouk, Joy Vargese, Mohamed Rela – 10 October 2017